Veronika Weyerer

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

Sia V. Lindskrog, Frederik Prip, Philippe Lamy et al. · Nature Communications · 2021 · 379 citations · Full text

Medicine, Oncology, Urology +17

The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes

Carolin Pfannstiel, Pamela L. Strissel, Katherine B. Chiappinelli et al. · Cancer Immunology Research · 2019 · 232 citations

Medicine, Oncology, Urology +17

Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

Markus Eckstein, Philipp Erben, Maximilian C. Kriegmair et al. · European Journal of Cancer · 2018 · 103 citations

Medicine, Oncology, Pharmacology +16

Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype

Ulrike Zinnall, Veronika Weyerer, Éva Compérat et al. · Human Pathology · 2018 · 62 citations · Full text

Medicine, Oncology, Pathology +15

Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy

Markus Eckstein, Pamela L. Strissel, Reiner Strick et al. · Journal for ImmunoTherapy of Cancer · 2020 · 58 citations · Full text

Medicine, Immunology, Oncology +17